Acute Pain Clinical Trials 2023

Acute Pain Clinical Trials 2023

Acute Pain research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in acute pain clinical trials today.

Trials for Chronic Pain Patients

Trials for Postoperative Pain Patients

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to acute pain

What are the top hospitals conducting acute pain research?

When it comes to advancing the field of acute pain management, several hospitals are leading the way with their dedication to clinical trials. One such institution is the University of California, San Diego in sunny San Diego. Currently, they have four ongoing trials focused on acute pain while having completed a total of seven studies throughout their history. The hospital recorded its very first acute pain trial in 2021, reflecting their commitment to staying at the forefront of innovative research. In Wilmington, Delaware, Nemours Children's Health System is making waves with two active trials and an equal number of previous studies dedicated to understanding and managing acute pain. This renowned children's health system made its foray into acute pain research just recently in 2021 but has already shown promising progress.

The University of Florida - Gainesville joins this esteemed group by contributing valuable insights through two current acute pain trials and adding another two previously conducted investigations under its belt since initiating research in this area also back in 2021.The Nemours Children's Health System extends its influence beyond Wilmington as it demonstrates unwavering dedication across multiple locations. In both Jacksonville and Orlando branches, Nemours has undertaken two active acute pain trials each while matching that count with an equal number accomplished before; all three locations simultaneously embarked on analyzing different aspects surrounding tackling this condition starting off their journey alongside last year i.e., 2021

These hospitals' commitment to studying and addressing acute pain highlights their role as pioneers in providing optimal care for patients experiencing this debilitating condition. By conducting rigorous clinical trials and continuously expanding knowledge about effective treatments, these institutions pave the way toward improved quality of life for individuals dealing with acute pain worldwide

Which are the best cities for acute pain clinical trials?

When it comes to acute pain clinical trials, several cities emerge as key players in advancing research and treatment. In San Diego, California, there are 7 active trials investigating interventions such as Active bupivacaine 0.25%, Pulsed Shortwave Treatment, and Percutaneous Auricular Neuromodulation. Nashville, Tennessee follows closely with 6 ongoing studies focused on immediate pharmacogenetic testing for acute pain management. Indianapolis, Indiana has 5 active trials exploring the effects of pharmacogenetic testing and Gabapentin treatment for patients experiencing acute pain. Meanwhile, Hamilton in Ontario and Chicago both have 4 active trials examining various interventions ranging from Cognitive Behavioral Therapy to exercise interventions for veterans. These cities provide opportunities for individuals suffering from acute pain to participate in cutting-edge clinical trials that pave the way for improved treatments and better quality of life.

Which are the top treatments for acute pain being explored in clinical trials?

Exciting developments are taking place in the realm of acute pain treatments, with several notable contenders emerging from ongoing clinical trials. Leading the pack is the intervention group, currently being tested in two active trials and making its mark on the acute pain landscape since 2015. Another promising candidate is VX-548, which has garnered attention with two active trials and a total of five all-time acute pain studies since its debut in 2021. Pharmacogenetic testing also shows promise with two ongoing trials and three all-time acute pain investigations initiated in 2021. Lastly, SBS-1000 exhibits potential as it undergoes evaluation in one active trial, marking its introduction to the field in 2023. These advancements signal hope for more effective management of acute pain conditions moving forward.

What are the most recent clinical trials for acute pain?

Recent clinical trials for acute pain offer promising advancements in pain management. One notable study focuses on the use of intravenous oxytocin, which has shown potential in relieving acute pain. Additionally, high-dose treatments have been explored as a possible solution to alleviate acute pain symptoms effectively. Furthermore, eHealth mindful movement and breathing groups have been investigated to determine their efficacy in managing acute pain. In another trial, low-dose group B1 was tested to evaluate its effectiveness in providing relief from acute pain. These ongoing studies are crucial steps towards enhancing our understanding and treatment options for individuals suffering from acute pain.

What acute pain clinical trials were recently completed?

Several recent clinical trials have made significant strides in the field of acute pain management, presenting promising outcomes for patients. In August 2021, Vertex Pharmaceuticals Incorporated completed a trial investigating the potential of VX-548 as a treatment option. Notably, another trial exploring VX-548 was concluded just one month prior in July 2021. Additionally, other completed trials included investigations into Bupivacaine 0.375% (April 2021), Naproxen (February 2021), Tolperisone Hydrochloride (December 2020), Ketamine plus usual care (July 2020). While earlier studies on Pain Induction and Ibuprofen were finalized in May 2019 under the sponsorship of Syracuse University and University of Pennsylvania respectively. These advancements provide valuable insights and pave the way for improved acute pain management strategies going forward.